SMAD3 and cancer: To next evaluate the impact of SMAD2 or SMAD3 modulation on the invasive properties of cancer cells in hypoxia, we compared the capacity of HT-1080 and MDA-MB-231 knockdown cells to produce invadopodia under normoxic versus hypoxic conditions.